Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Immune Checkpoint Inhibitors × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Squamous Cell Carcinoma of Head and Neck 4 Melanoma 4 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Triple Negative Breast Neoplasms 2 Solid Cancers 2 Rectal Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Breast Neoplasms 2 Turcot syndrome 1 Stomach Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Extensive Stage 1 Skin Neoplasms 1 Sarcopenia 1 Sarcoma, Synovial 1 Sarcoma, Ewing 1 Sarcoma 1 SCLC 1 Rhabdomyosarcoma 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Oropharyngeal Neoplasms 1 Neoadjuvant Therapies 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1

Interventions

Carboplatin 5 pembrolizumab 3 Specimen Handling 3 Magnetic Resonance Spectroscopy 3 fludarabine phosphate 2 Taxes 2 Radiotherapy 2 Radiation 2 Pemetrexed 2 Paclitaxel 2 Cyclophosphamide 2 Biopsy 2 veliparib 1 methoxyamine 1 fludarabine 1 durvalumab 1 dapagliflozin 1 capmatinib 1 aldesleukin 1 Standard of Care 1 Smoking Devices 1 Radiotherapy, Image-Guided 1 Radiotherapy, Conformal 1 Radiosurgery 1 Practice Guidelines as Topic 1 Platinum 1 Nivolumab 1 Ipilimumab 1 Interleukin-2 1 Interleukin-13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡